Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a ...
Our scientists empower researchers with new technologies, methods development, sample analysis, expert training, and consultation. We are an academic research laboratory and not a GLP or GMP facility.
Total revenue of $59.3 million for the fiscal year ended December 31, 2024Expect double digit growth for total revenue in 20252025 to demonstrate ...
HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback